In Vivo Evaluation of the Efficacy of Adipose‐Derived Mesenchymal Stem Cell Secretome in MRSA‐Infected Burn Wounds
Stem Cells International · 2026-01 · 2026 (1)
DOI: 10.1155/sci/5242909 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cells International, online erschienen am 18.11.2026. Verfasst von Lama Hanbali und 4 weiteren Autor:innen. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Methicillin‐resistant Staphylococcus aureus (MRSA) remains a major contributor to antimicrobial resistance, complicating clinical management, particularly in burn patients who are highly prone to infection. Adipose‐derived mesenchymal stem cells (AD‐MSCs) have emerged as a promising adjuvant therapy, primarily through the paracrine secretion of bioactive factors. The study aimed to assess the potential of AD‐MSC‐derived secretome as an adjunctive biological therapy for MRSA‐infected wounds.
Methods
In vitro and in vivo antibacterial activity of the secretome was assessed. Histological analysis was also performed to assess re‑epithelialization, inflammatory cell infiltration, and collagen deposition.
Results
In vitro, the AD‐MSC secretome exhibited antibacterial activity against methicillin‐sensitive Staphylococcus aureus (MSSA) and most MRSA isolates, with significantly greater inhibition against MSSA. In vivo, AD‐MSC secretome treatment significantly reduced bacterial burden. Moreover, it revealed greater wound closure percentage compared with untreated wounds, although this difference was not statistically significant. Histological evaluation showed enhanced re‐epithelialization and collagen deposition, accompanied by reduced inflammatory cell infiltration in AD‐MSC secretome‐treated wounds.
Conclusions
These findings demonstrated the antibacterial activity of AD‐MSC secretome both in vitro and in vivo, while also highlighting its potential contribution to tissue repair and wound healing. Overall, our results support further investigation of AD‐MSC secretome as a potential adjunct to conventional antibiotic therapy for MRSA‐infected burn wounds.
Zitieren
APA
Hanbali, L., Ali, L., Khalil, C., Sokhn, E. S., & Saleh, F. A. (2026). In Vivo Evaluation of the Efficacy of Adipose‐Derived Mesenchymal Stem Cell Secretome in MRSA‐Infected Burn Wounds. Stem Cells International, 2026(1). https://doi.org/10.1155/sci/5242909
Vancouver
Hanbali L, Ali L, Khalil C, Sokhn ES, Saleh FA. In Vivo Evaluation of the Efficacy of Adipose‐Derived Mesenchymal Stem Cell Secretome in MRSA‐Infected Burn Wounds. Stem Cells International. 2026;2026(1). doi:10.1155/sci/5242909
BibTeX
@article{Hanbali2026,
author = {Hanbali, Lama and Ali, Leen and Khalil, Charbel and Sokhn, Elie Salem and Saleh, Fatima A.},
title = {In Vivo Evaluation of the Efficacy of Adipose‐Derived Mesenchymal Stem Cell Secretome in MRSA‐Infected Burn Wounds},
journal = {Stem Cells International},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/sci/5242909}
}
EUVIMED